443
Views
16
CrossRef citations to date
0
Altmetric
Studies in Humans

Alterations of antioxidant status in asymptomatic hypercholesterolemic individuals after resveratrol intake

, , &
Pages 541-552 | Received 09 Nov 2015, Accepted 31 Mar 2016, Published online: 24 Apr 2016

References

  • Abuohashish HM, Aleisa AM, Ahmed MM, Alkhamees OA, Al-Rejaie SS, Alroujayee AS. 2013. Ameliorative effects of rutin and ascorbic acid combination on hypercholesterolemia-induced hepatotoxicity in female rats. Afr J Pharm Pharmacol. 7:280–288.
  • Akar F, Uluda O, Aydın A Aytekin YA, Elbeg S, Tuzcu M, Sahin K. 2012. High-fructose corn syrup causes vascular dysfunction associated with metabolic disturbance in rats: protective effect of resveratrol. Food Chem Toxicol. 50:2135–2141.
  • Alonso A, Guillean D, Barroso C, Puertas B, Garcia A. 2002. Determination of antioxidant activity of wine byproducts and its correlation with polyphenolic content. J Agric. Food Chem. 50:5832–5836.
  • Altekin ER, Demir I, Basarici I, Yilmaz H. 2007. The relationship between carotid intima-media thickness and the presence and extent of angiographic coronary artery disease. Turk Kardiyol Dern Ars. 35:90–96.
  • Apostolidou C, Adamopoulos K, Lymperaki E, Iliadis S, Papapreponis P, Kourtidou-Papadeli C. 2015. Cardiovascular risk and benefits from antioxidant dietary intervention with red wine in asymptomatic hypercholesterolemics. Clin Nutr. (10):e224–e233.
  • Arnaud J, Fortis I, Blachier S, Favier K, Favier A. 1991. Simultaneous determination of retinol, a-tocopherol, and β-carotene in serum by isocratic high-performance liquid chromatography. J Chromatogr. 572:103–101.
  • Arora A, Nair MG, Strasburg GM. 1998. Structure activity relationships for antioxidant activities of a series of flavonoids in a liposomal system. Free Radic Biol Med. 24:1355–1363.
  • Azzi A, Breyer I, Feher M, Pastori M, Ricciarelli R, Spycher S, Staffieri M, Stocker A, Zimmer S, Zingg JM. 2000. Specific cellular responses to alpha-tocopherol. J Nutr. 130:1649–1652.
  • Bo S, Ciccone G, Castiglione A, Gambino R, De Michieli F, Villois P, Durazzo M, Cavallo-Perin P, Cassader M. 2012 . Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Curr Med Chem. 20:1323–1331.
  • Charles CA, Lucy SP, Cicely SGC, Richmond W, Paul CF. 1974. Enzymatic determination of total serum cholesterol. Clin Chem. 20:470–475.
  • Cook NC, Samman S. 1996. Flavonoids-Chemistry, metabolism, cardioprotective effects, and dietary sources. Nutr Biochem. 7:66–76.
  • Das DK, Maulik N, Sato M, Ray PS. 1999. Reactive oxygen species function as second messenger during ischemic preconditioning of the heart. Mol Cell Biochem. 196:9–67.
  • Das DK, Maulik N. 2006. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv. 6:36–47.
  • Das DK, Mukherjee S, Ray D. 2011. Erratum to: resveratrol and red wine, healthy heart and longevity. Heart Fail Rev. 16:425–435.
  • Das S, Snehlata MP, Srivastava LM. 1997. Effect of ascorbic acid on lipid profile and lipid peroxidation in hypercholesterolemic rabbits. Nutr Res. 17:231–241.
  • De la Lastra CA, Villegas I. 2005 . Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res. 49:405–430.
  • Djordjević VB, Zvezdanović L, Cosić V. 2008. Oxidative stress in human diseases. Srp Arh Celok Lek. 136:158–165.
  • Fang JG, Zhou B. 2008 . Structure-activity relationship and mechanism of the tocopherol-regenerating activity of resveratrol and its analogues. J Agric Food Chem. 56:11458–11463.
  • Farombi EO, Fakoya A. 2005. Free radical scavenging and antigenotoxic activities of natural phenolic compounds in dried flowers of Hibiscus sabdariffa. L. Mol Nutr Food Res. 49:1120–1128.
  • Flora JSS. 2009. Structural, chemical and biological aspects of antioxidants for strategies against metal and metalloid exposure. Oxid Med Cell Longev. 2:191–206.
  • Fremont L. 2000. Biological effects of resveratrol. Life Sci. 66:663–673.
  • Frohlich JJ. 1996. Effects of alcohol on plasma lipoprotein metabolism. Clin Chim Acta. 246:39–49.
  • Fujitaka K, Otani H, Jo F, Jo H, Nomura E, Iwasaki M, Nishikawa M, Iwasaka T, Das DK. 2011. Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment. Nutr Res. 31:842–847.
  • Gemma CB, Chiva-Blanch Arranz S, Lamuela-Raventos RM Estruch R. 2013 . Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies. Alcohol Alcohol. 48:270–277.
  • Glascott PA Jr, Farber JL. 1999. Assessment of physiological interaction between vitamin E and Vitamin C. Meth Enzymol. 300:78–88.
  • Guanim H, Sia CL, Korzeniewski K, Lohano T, Abuaysheh S, Marumganti A, Chaudhuri A, Dandona P. 2011. A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab. 96:1409–1414.
  • Guarda E, Godoy I, Foncea R, Pérez DD, Romero C, Venegas R, Leighton F. 2005. Red wine reduces oxidative stress in patients with acute coronary syndrome. Int J Cardiol. 104:35–38.
  • Harats D, Chevion S, Nahir M, Norman Y, Sagee O, Berry EM. 1998. Citrus fruit supplementation reduces lipoprotein oxidation in young men ingesting a diet high in saturated fat: presumptive evidence for an interaction between vitamin C and E in vivo. Am J Clin Nutr. 67:240–245.
  • Hattori R, Otani H, Maulik N, Das DK. 2002. Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol Heart Circ Physiol. 282:H1988–H1995.
  • Heger A, Ferk F, Nersesyan A, Szekeres T, Kundi M, Wagner KH, Haidinger G, Mišík M, Knasmüller S. 2012. Intake of a resveratrol-containing dietary supplement has no impact on DNA stability in healthy subjects. Mutat Res. 749:82–86.
  • Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. 1993. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet. 342:1007–1011.
  • Inanaga K, Ichiki T, Matsuura H Miyazaki R, Hashimoto T, Takeda K, Sunagawa K. 2009. Resveratrol attenuates angiotensin II-induced interleukin-6 expression and perivascular fibrosis. Hypertens Res. 32:466–471.
  • Juntachote T, Berghofer E. 2005. Antioxidative properties and stability of ethanolic extracts of Holy basil and Galangal. Food Chem. 92:193–202.
  • Kagan VE, Tyurina YY. 1998. Recycling and redox cycling of phenolic antioxidants. Towards prolongation of the healthy life span. Ann NY Acad Sci. 854:425–434.
  • Kopp P. 1998. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur J Endocrinol. 138:619–620.
  • Lata S, Das S, Srivastava LM. 1997. Ascorbic acid in relation to lipid peroxidation in hypercholesterolemic guinea pigs. J Clin Biochem Nutr. 23:165–175.
  • Liu K, Cuddy TE, Pierce GN. 1992. Oxidative status of lipoproteins in coronary disease patients. Am Heart J. 123:285–290.
  • Liu Y, Ma W, Zhang P, He S, Huang D. 2015. Effect of resveratrol on blood pressure: A meta-analysis of randomized controlled trials. Clin Nutr. 34:27–34.
  • Liu Z, Song Y, Zhang X, Zhang W, Mao W, Wang W, Cui W, Zhang X, Jia X, Li N, et al. 2005. Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model. Clin Exp Pharmacol Physiol. 32:1049–1054.
  • Magyar K, Halmosi R, Palfi A Feher G, Czopf L, Fulop A, Battyany I, Sumegi B, Toth K, Szabados E. 2012. Cardioprotection by resveratrol: a human clinical trial in patients with stable coronary artery disease. Clin Hemorheol Microcirc. 50:179–187.
  • Meng C, Liu JL, Du AL. 2014 . Cardioprotective effect of resveratrol on atherogenic diet-fed rats. Int J Clin Exp Pathol. 7:7899–7908.
  • Meng Y, Ying W, Davis CG, Sang Gil L, Maria Luz F, Sung IK, Eunyoung C, Chun O K. 2011. Validation of an FFQ to assess antioxidant intake in overweight postmenopausal women. Public Health Nut. 17:297–306
  • Micallef M, Lexis L, Lewandowski P. 2007. Red wine consumption increases antioxidant status and decreases oxidative stress in the circulation of both young and old humans. Nutr J. 6:27–20.
  • Militaru C, Donoiu I, Craciun A Scorei ID, Bulearca AM, Scorei RI. 2013 . Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: effects on lipid profiles, inflammation markers, and quality of life. Nutrition. 29:178–183.
  • Miller YI, Choi SH, Fang L, Tsimikas S. 2010. Lipoprotein modification and macrophage uptake: role of pathologic cholesterol transport in atherogenesis. Subcell Biochem. 51:229–251.
  • Opie LH, Lecour S. 2007. The red wine hypothesis: from concepts to protective signalling molecules. Eur Heart J. 28:1683–1693.
  • Ordovas-Montanes JM, Ordovas JM. 2012. Cholesterol, inflammasomes, and atherogenesis. Curr Cardiovasc Risk Rep. 6:45–52.
  • Ricciarelli R, Zingg JM, Azzi A. 2001. Vitamin E: protective role of a Janus molecule. FASEB J. 15:2314–2325.
  • Rice-Evans CA. 2000. Measurement of total antioxidant activity as a marker of antioxidant status in vivo: procedures and limitations. Free Radic Res. 33:S59–S66.
  • Riley PA. 1994 . Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol. 65:27–33.
  • Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. 1993. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 328:1450–1456.
  • Robich MP, Osipov RM, Nezafat R Feng J, Clements RT, Bianchi C, Boodhwani M, Coady MA, Laham RJ, Sellke FW. 2010. Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia. Circulation. 122:S142–S149.
  • Sabari D, Suman V, Snehlata ND, Srivastava LM. 2000. Correlation between total antioxidant status and lipid peroxidation in hypercholesterolemia. Curr Sci. 78:486–487.
  • Soares DG, Andreazza AC, Salvador M. 2003. Sequestering ability of butylated hydroxytoluene, propyl gallate, resveratrol, and vitamins C and E against ABTS, DPPH, and hydroxyl free radicals in chemical and biological systems. J Agric Food Chem. 51:1077–1080.
  • Spanier G, Xu H, Xia N, Tobias S, Deng S, Wojnowski L, Forstermann U, Li H. 2009. Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol. 60:111–116.
  • Stringer MD, Gorog PG, Freeman A, Kakkar VV. 1989. Lipid peroxides and atherosclerosis. BMJ. 298:281–284.
  • Thandapilly SJ, Wojciechowski P, Behbahani J, Louis XL, Yu L, Juric D, Kopilas MA, Anderson HD, Netticadan T. 2009. Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. Am J Hypertens. 23:192–196.
  • Tomé-Carneiro J, Gonzálvez M, Larrosa M, García-Almagro FJ, Avilés-Plaza F, Parra S, Yáñez-Gascón MJ, Ruiz-Ros JA, García-Conesa MT, Tomás-Barberán FA, Espín JC., 2012 . Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial. Mol Nutr Food Res. 56:810–821.
  • Tomé-Carneiro J, Gonzálvez M, Larrosa M, Yáñez-Gascón MJ, García-Almagro FJ, Ruiz-Ros JA, Tomás-Barberán FA, García-Conesa MT, Espín JC. 2013. Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells a triple-blind placebo-controlled one year clinical trial in patients with stable coronary artery disease. Cardiovasc Drugs Ther. 27:37–48.
  • Ungvari Z, Bagi Z, Feher A, Recchia FA, Sonntag WE, Pearson K, de Cabo R, Csiszar A. 2010. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Physiol Heart Circ Physiol. 299:H18–H24.
  • Van der Made SM, Plat J, Mensink RP. 2015. Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial. PLoS One. 10:e0118393.
  • Wang Z, Zou J, Cao K, Hsieh TC, Huang Y, Wu JM. 2005. Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int J Mol Med. 16:533–540.
  • Wright ME, Lawson KA, Weinstein SJ, Pietinen P, Taylor PR, Virtamo J, Albanes D. 2006. Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the alpha-tocopherol, beta-carotene cancer prevention study. Am J Clin Nutr. 84:1200–1207.
  • Yoshino J, Conte C, Fontana L, Mittendorfer B, Imai S, Schechtman KB, Gu C, Kunz I, Rossi Fanelli F, Patterson BW, Klein S. 2012. Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab. 16:658–664.
  • Zhang PY, Xu X, Li XC. 2014. Cardiovascular diseases: oxidative damage and antioxidant protection. Eur Rev Med Pharmacol Sci. 18:3091–3096.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.